Are there any new developments in medical mycology?
“News moves prudently in the sciences and even more so in life sciences pertaining to human health. In the field of genomics, molecular biologists made a key finding based upon the DNA of a bacteria. One of the causes of pneumonia identified as Pneumocystis carinii, a parasitic protozoan bacteria, has been reclassified and identified as a fungi due to genomics was renamed in 1999 as Pneumocystis jiroveci. For medical mycologists this was an interesting discovery and an important reclassification for treatment of pneumonia.” Yes, but what does that mean? “Good question, it answers what medical mycology and molecular medicine is all about. Simply fungi, plants bacteria and humans all have a different molecular and cellular makeup. Drugs are designed to target the difference in the cells, cell function, their internal organs and reproduction. There has been an increase in optimism for the health care profession because of this research and we now have pharmaceuticals designing their drugs
